WHO FACES FUNDING CRISIS AMID US WITHDRAWAL AND CUTS
The World Health Organization (WHO) is facing a severe funding crisis following the abrupt withdrawal of U.S. support, which historically made up 18% of its budget. WHO Director-General Tedros Adhanom Ghebreyesus announced major restructuring—cutting senior leadership by half and departments from 76 to 34—to address a projected $500 million salary gap. The organization’s 2026–2027 budget was reduced from a proposed $5.3 billion to $4.2 billion, still leaving a $1.7 billion shortfall. Tedros stressed the inadequacy of the current funding, noting the WHO now operates on a budget comparable to a single hospital in Geneva. The U.S. also owes $260 million in unpaid dues. Despite recent fundraising efforts, the organization remains significantly underfunded while continuing to operate in over 150 countries. High-profile departures, including Michael Ryan and Bruce Aylward, underscore the difficult choices being made as the agency adapts to reduced resources amidst growing global health challenges. (Ars Technica)
xAI BLAMES UNAUTHORIZED PROMPT CHANGE FOR GROK GLITCH
Elon Musk’s AI company, xAI, has blamed an “unauthorised modification” for a controversial glitch in its Grok chatbot, which made repeated false claims about a “white genocide” in South Africa. The issue, triggered by seemingly unrelated user prompts, led the bot to veer into discredited political narratives promoted by figures like Donald Trump. xAI stated that the glitch was caused by an unsanctioned change to Grok’s system prompt—its internal guiding instructions—violating company policy. In response, xAI pledged tighter controls, including restricting prompt modifications to reviewed processes, launching a 24/7 monitoring team, and publishing Grok’s prompts openly on GitHub for transparency. The bot’s comments echoed recent political rhetoric, including Trump’s granting of asylum to 54 white South Africans and labeling Afrikaners as victims of genocide—claims strongly refuted by South African President Cyril Ramaphosa as entirely false. The incident raises concerns about internal safeguards and political manipulation of AI systems. (The Guardian)
REPORT FINDS TERROR GROUPS USING PAID X SERVICES
Two years after Elon Musk vowed to make Twitter (now X) a welcoming platform for all, a new report by the Tech Transparency Project (TTP) reveals that sanctioned terrorist groups, including Hezbollah, Hamas, and the Houthis, are actively using X’s paid premium services. These $8-per-month subscriptions grant extremist accounts blue check marks and algorithmic boosts, enhancing their ability to spread propaganda. Despite a previous warning from TTP in early 2024, X only briefly removed some accounts, many of which quickly resurfaced. The platform’s apparent financial transactions with sanctioned groups may violate U.S. Treasury Department regulations under OFAC. X’s lack of stringent content moderation and identity verification raises questions about its role in amplifying militant messaging. The report also highlights high-profile users like Mahdi al-Mashat and Subhi Tufayli, whose accounts remain active. Though impersonation remains a possibility, the widespread presence of extremist content and monetization exposes serious ethical and potentially legal lapses under Musk’s leadership. (Gizmodo)
TRUMP UNVEILS MASSIVE AI DEALS IN GULF TOUR
During a recent Middle East tour, Donald Trump unveiled sweeping AI partnerships aimed at reshaping global tech power. In Abu Dhabi, Trump announced U.S. companies would help Emirati firm G42 build a five-gigawatt AI datacenter cluster, the largest outside America. In Riyadh, Saudi Arabia launched Humain, an AI investment firm backed by blockbuster deals with Nvidia, AMD, AWS, and Qualcomm. These partnerships promise billions in infrastructure investment and massive GPU acquisitions, potentially allowing the region to develop frontier AI models. The deals align Gulf nations more closely with U.S. tech interests, despite their ongoing ties to China. Trump’s administration also reversed Biden-era chip export restrictions, enabling wider access to advanced U.S. hardware. Experts say the initiatives could secure U.S. influence over global AI while helping Saudi Arabia and the UAE become major players. However, risks remain: future tech rivalry, chip smuggling to China, and deeper geopolitical entanglements in the U.S.–China tech race. (Wired)
GENOMIC STUDY REVEALS BRAZIL’S COMPLEX ANCESTRAL LANDSCAPE
A landmark genomic study published in Science has mapped Brazil’s genetic diversity in unprecedented detail, revealing how colonization, slavery, and migration have shaped the country’s biology and health. Researchers sequenced the genomes of over 2,700 individuals, including underrepresented Afro-Brazilian and Indigenous communities. They found Brazilians have, on average, 59% European, 27% African, and 13% Indigenous ancestry—distinct from other Latin American countries. The study highlights Brazil’s history of forced labor, government-sponsored “whitening,” and genetic evidence of colonial-era sexual coercion. Over 8.7 million previously unknown genetic variants were identified, including 36,000 potentially disease-linked ones. Some rare, damaging variants are more associated with African ancestry. The findings aim to support personalized medicine and health equity, especially for marginalized populations. This is the first paper from the DNA of Brazil initiative, which plans to sequence 100,000 genomes by 2030 to revolutionize healthcare and counteract the legacy of racism in Brazilian medicine and science. (Science)
NEW EVOCAST TOOL ADVANCES SAFE PRECISE GENE INSERTION
A new genome-editing tool called evoCAST promises to revolutionize gene therapy by enabling the precise, efficient insertion of entire genes into human DNA—without cutting the genome. Published in *Science*, the system builds on CRISPR-associated transposases (CAST), bacterial enzymes that can move large genetic elements. Developed by David Liu and Samuel Sternberg, evoCAST was created through directed evolution, enhancing integration efficiency by over 400-fold. It can insert long DNA segments—over 10,000 nucleotides—into “safe harbor” regions of the genome in a single step, reducing risks of mutations and increasing scalability. Other research groups are also exploring transposon-based tools, signaling a broader shift toward safer gene-editing techniques that avoid double-strand breaks. Although evoCAST’s large size complicates delivery and rare off-target insertions still occur, scientists view it as a major advance toward next-generation cell therapies, personalized medicine, and disease modeling. As Sternberg notes, the field is only beginning to harness these tools’ full potential. (Nature)
US AID CUTS TRIGGER CHILD HUNGER CRISIS WORLDWIDE
Massive U.S. foreign aid cuts, particularly from USAID, have devastated humanitarian operations in Nigeria and beyond, leading to surging child malnutrition and death. In Borno State, Nigeria, over 400,000 displaced people, including Yagana Bulama who lost one of her twins, rely on aid that’s now disappearing. USAID previously funded 50% of therapeutic foods for malnourished children globally, but the Trump administration slashed over 90% of contracts, imperiling programs in Nigeria, Nepal, and Bangladesh. Aid groups like Mercy Corps and Helen Keller Intl have been forced to shut down or scale back, overwhelming the few remaining facilities. Intersos, one of the last health providers in Dikwa, reduced staff by over half and faces a funding cliff in June. The crisis extends beyond nutrition, impacting housing, healthcare, and displacement centers. Globally, over 40 Mercy Corps programs have been terminated, affecting millions. Without urgent replacement funding, aid workers warn of rising child mortality and instability. (AP)
CRISPR SAVES INFANT WITH RARE GENETIC DISORDER
In a medical first, researchers have used a personalized version of CRISPR gene editing to treat a baby boy with a rare, life-threatening genetic disorder. At just seven months old, the child received an experimental therapy targeting a mutation that disrupts a key liver enzyme, causing dangerous ammonia buildup. While the treatment isn’t a cure—he still requires a special diet and medication—it successfully repaired the faulty gene in some liver cells, reducing symptoms. The case, detailed in The New England Journal of Medicine, marks a milestone for precision medicine and gene therapy for rare diseases. Experts hail it as a significant proof of concept, showing how tailored gene editors can be rapidly developed and deployed for individual patients. Neurologist Timothy Yu called the effort “heroic,” underscoring its importance for future treatments targeting ultra-rare genetic mutations that affect only a handful of patients worldwide. (Science)
LAB-GROWN AMNIOTIC SACS ADVANCE EARLY PREGNANCY RESEARCH
Researchers have successfully grown lab-made amniotic sacs from stem cells, creating fluid-filled structures that closely resemble those found around four-week-old human embryos. Published in Cell, the study marks the most advanced model of the amniotic sac to date. Using sequential signaling molecules, scientists at the Francis Crick Institute guided stem cells to self-organize into sacs about 2 cm wide over three months. These sacs displayed key features like a two-layer membrane, fluid similar to real amniotic fluid, and a transient yolk sac-like structure. The model allows researchers to analyze early pregnancy development and extract fluid for study, offering a potential tool for understanding fetal health. However, experts caution that it’s still unclear how well the model mimics later stages of development, when many pregnancy complications arise. Future plans include placing embryo-like cells inside the sacs to explore interactions, which could enhance the model’s biological relevance and utility in reproductive research. (Nature)
CHICAGO ARCHAEOPTERYX FOSSIL REWRITES EARLY BIRD FLIGHT
A newly studied Archaeopteryx fossil, known as the Chicago Archaeopteryx, is reshaping scientific understanding of early bird evolution and flight. Discovered in Germany and acquired by the Field Museum in 2022, the fossil features remarkably preserved soft tissues and three-dimensional bones—unlike earlier, flattened specimens. Using CT scanning and UV light, researchers led by Dr. Jingmai O’Connor uncovered previously unseen anatomical details, including a third layer of wing feathers, which in modern birds enables more sustained flight. The wing structure contrasts with other feathered, non-avian dinosaurs, suggesting Archaeopteryx had limited but real flight capability—akin to a Jurassic roadrunner. Its preserved toe pads also support the idea that it was ground-dwelling and capable of short bursts of flight. The study, published in Nature, highlights how even a well-known fossil species can still yield surprises and new insights. As Dr. O’Connor noted, “This specimen’s going to keep me busy for years.” (New York Times)
Thanks for reading. Let’s be careful out there.
WORDS: The Biology Guy.
IMAGE CREDIT: NASA.
Leave a Reply